Bronchoscopic tissue yield for advanced molecular testing: Are we getting enough?
© Journal of Thoracic Disease. All rights reserved. The treatment of advanced lung cancer has become increasingly personalized over the past decade as a result of the improved understanding of tumor molecular biology and anti-tumor immunity. An adequate tumor sample is central to targetable mutation...
Saved in:
Main Authors: | Pattraporn Tajarernmuang, Linda Ofiara, Stéphane Beaudoin, Anne V. Gonzalez |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091652558&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70848 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Are we doing enough?
by: Marave, Angelita G., SJGS
Published: (1991) -
Eclampsia - Are we doing enough?
by: Low, JJH, et al.
Published: (2021) -
Intractable pleural effusion in Kaposi sarcoma following antiretroviral therapy in a Caucasian female infected with HIV
by: Pattraporn Tajarernmuang, et al.
Published: (2020) -
Bronchoscopic lung volume reduction
by: Ernst, A, et al.
Published: (2020) -
Whatever We're Doing - It's Not Enough.
by: Stoner, James A. F.
Published: (2022)